HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsPricing
Theme
Help Login Register
Market News Stocks News ETF News Crypto News

ArriVent BioPharma, Inc.

Contributing Author

Recent Articles by ArriVent BioPharma, Inc.

Jul-01
ArriVent Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants AVBP GlobeNewswire
Jul-01
ArriVent Announces Proposed $75 Million Public Offering of Common Stock and Pre-Funded Warrants AVBP GlobeNewswire
Jun-23
ArriVent Announces Positive Interim Firmonertinib Monotherapy Data From Global Phase 1b Study in EGFR PACC Mutant Non-Small Cell Lung Cancer and Plans to Advance into a Global Pivotal Study AVBP GlobeNewswire
Jun-20
ArriVent Announces Investor Event on Firmonertinib Path Forward for EGFR PACC Mutant NSCLC AVBP GlobeNewswire
May-12
ArriVent BioPharma Reports First Quarter 2025 Financial Results AVBP GlobeNewswire
Affiliate • Advertise • Theme Settings • Contact • Help • Privacy • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.

Upgrade your FINVIZ experience

Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.

Learn more about FINVIZ*Elite